Text Size

Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents

Tsuji F., Murai M., Oki K., Seki I., Ueda K., Inoue H., Nagelkerken L., Sasano M., Aono H.


  • 2010
  • European Journal of Pharmacology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology

    Other

  • Affiliations

    Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma-shi, Nara, 630-0101, Japan; United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan; Department of Inflammatory and Degenerative Diseases, TNO Quality of Life, Zernikedreef 9, 2333 CK Leiden, Netherlands; Functional Polymer Science Laboratory, Graduate School of Materials Sciences, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma-shi, Nara, 630-0192, Japan

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022